Christoph Dahlhoff
10Patents
3h-index
29Co-inventors
52Inventor score
Filing activity: Apr 18, 2016 → Jun 2, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10294300B2 | Antibody constructs for DLL3 and CD3 | Chemistry; Metallurgy | 28 | Active |
| US11692031B2 | Antibody constructs for CLDN18.2 and CD3 | Chemistry; Metallurgy | 5 | Active |
| US10683351B2 | Antibody constructs for DLL3 and CD3 | Chemistry; Metallurgy | 4 | Active |
| US11591396B2 | Antibody constructs for DLL3 and CD3 | Chemistry; Metallurgy | 3 | Active |
| US11447567B2 | Antibody constructs for FLT3 and CD3 | Chemistry; Metallurgy | 2 | Active |
| US11926666B2 | Bispecific antibody constructs for CDH3 and CD3 | Chemistry; Metallurgy | 0 | Active |
| US12258411B2 | Anti-CCR8 antibodies and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US11028171B2 | Bispecific antibody constructs for CDH3 and CD3 | Chemistry; Metallurgy | 0 | Active |
| US12304952B2 | Antibody constructs for DLL3 and CD3 | Chemistry; Metallurgy | 0 | Active |
| US12258404B2 | Bispecific antibody construct directed to MUC17 and CD3 | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.